Financial insights of SONM

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total net revenues	-	-	16,214	11,190
Cost of revenues	-	-	14,398	10,345
Gross profit	-	-	1,816	845
Research and development	-	-	181	909
Sales and marketing	-	-	2,452	3,445
General and administrative	3,618	-3,819	3,163	3,223
Impairment of contract fulfillment assets	-	-	-	0
Total operating expenses	3,618	-15,678	5,796	7,577
Net gain from operations	-3,618	4,661	-3,980	-6,732
Interest expense, net	-131	-484	-522	-389
Loss on extinguishment of debt	-	-161	-	-
Loss on remeasurement of derivative liability	-227	-	-	-
Equity income from dna x llc	48	-562	-161	-215
Net gain from continuing operations before income taxes	-3,928	3,454	-4,663	-7,336
Net loss from continuing operations	-3,928	-1,989*	-	-
Income tax expense	-	-	90	139
Income from discontinued operations, net of tax	10,268	-6,898*	-	-
Net income	6,340	-8,887	-4,753	-7,475

Basic EPS	5.01	-12.297	-4.83	-0.79
Diluted EPS	5.01	-12.297	-4.83	-0.79
Basic Average Shares	1,265,067	722,689*	984,927	9,510,601
Diluted Average Shares	1,265,067	722,689*	984,927	9,510,601

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.